Specialty Pharma Journal Specialty, Precision & Technology
ORCHARD PARK, N.Y., Nov. 15, 2017 /PRNewswire/ — An especially aggressive breast cancer cell can respond to hormone therapy if they express a specific protein known as estrogen receptor beta (ERβ), according to new research published on the cover of Oncotarget. The findings also revealed additional molecules that the researchers …
Tag Archives: Oncotarget
November, 2017
September, 2017
-
29 September
Individuals in the US Diagnosed with Cancer are 2.7 Times More Likely to Declare Bankruptcy
ORCHARD PARK, N.Y.–(BUSINESS WIRE)–As advancements in cancer therapies have been making headlines in recent years, cancer drug prices have significantly increased. The remaining question is, what are the economic impacts of the differentiations in cost of FDA approved drugs and the purchasing power of individuals around the world? This study, published …
May, 2016
-
5 May
Clinical Study Suggests the Origin of Glioblastoma Subtypes
Researchers at University of California San Diego School of Medicine have demonstrated that distinct types of glioblastoma, the most common form of brain cancer in adults, tend to develop in different regions of the brain. This finding provides an explanation for how the same cancer-causing mutation can give rise to …